迪纳明-1是癌症相关认知障碍的潜在调解者
bioRxiv : the preprint server for biology
|June 19, 2024
概括
癌症患者的Dynamin-1 (DNM1) 降低,特别是那些在治疗期间经历认知障碍的人. 这种Dynamin-1的下调与人类和动物模型中与癌症相关的认知障碍 (CRCI) 有关.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 动-1 (DNM1) 在突触功能和记忆巩固中起着至关重要的作用.
- DNM1已被研究为阿尔茨海默病的潜在治疗点.
- 与癌症相关的认知障碍 (CRCI) 是癌症患者的一个重大问题,影响生活质量.
研究的目的:
- 研究Dynamin-1 (DNM1) 在癌症相关认知障碍 (CRCI) 病变发生中的作用.
- 在青少年和年轻成人 (AYA) 癌症患者和临床前小鼠模型中检查DNM1水平.
- 确定DNM1下调是否与正在接受治疗的癌症患者的认知缺陷有关.
主要方法:
- 采用人类和动物模型的双重方法.
- 人类研究:86名参与者 (30名AYA癌症,56名对照) 在多个时间点完成了认知评估 (FACT-Cog) 和血液抽取.
- 动物研究:用于评估DNM1在脑中的表达,特别是海马亚子区域的表达,化学疗法后,使用了乳腺癌的合成小鼠模型.
主要成果:
- 与治疗前非癌症对照人群相比,癌症参与者中的DNM1水平明显较低.
- 认知障碍的癌症患者在治疗期间显示出显著的DNM1下调,与正常患者不同.
- 在小鼠模型中,化疗导致海马体CA1和CA3亚区域DNM1免疫活性显著下降.
结论:
- 在人类和动物研究中,都一直观察到Dynamin-1 (DNM1) 的下调,并且与与癌症相关的认知障碍 (CRCI) 的出现有关.
- 这些发现表明DNM1在CRCI病变发生过程中可能发挥作用.
- 需要进一步的研究来探索DNM1作为CRCI的治疗点.
相关概念视频
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Electron Transport Chain: Complex I and II
12.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.9K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


